Abstract
Alzheimer's disease (AD) is a neurodegenerative disease with a relevant negative impact on the individual's cognitive functions, behavior and daily activities. It presents a prevalence of 46.8 million people in the world population and without curative therapy so far. Studies have shown that a cerebral hypocholinergic state, characterized by reduction in the number of cholinergic neurons …